# To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.

> **NCT03161106** · NA · WITHDRAWN · sponsor: **Institute of Liver and Biliary Sciences, India**

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DIETARY_SUPPLEMENT:** Nutrition
- **DRUG:** Lactulose
- **DIETARY_SUPPLEMENT:** Diet

## Key facts

- **NCT ID:** NCT03161106
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-05-15
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** due lack of funds
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03161106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03161106, "To Assess Efficacy of Nutritional Therapy in Secondary Prophylaxis of Hepatic Encephalopathy Versus Lactulose in Patients With Liver Cirrhosis.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03161106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*